data_1f53_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1f53 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.547 ' CG2' ' N ' ' A' ' 2' ' ' ASP . 22.5 mm . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.614 0.721 . . . . 2.1699999999999999 110.3 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.547 ' N ' ' CG2' ' A' ' 1' ' ' ILE . 0.3 OUTLIER -158.5 166.61 31.76 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.598 -0.689 . . . . 2.1400000000000001 110.018 179.67 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.521 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -99.97 120.42 39.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.189 -0.944 . . . . 4.25 110.261 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' A' ' 28' ' ' TYR . 4.6 m -159.92 130.38 3.6 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.227 -0.92 . . . . 1.3500000000000001 110.161 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 6' ' ' CYS . 47.1 Cg_endo -73.67 57.05 3.59 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.978 1.515 . . . . 1.3600000000000001 110.668 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 1.123 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 7.7 m 57.51 160.5 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.156 -0.965 . . . . 1.3100000000000001 110.279 179.785 -43.707 -33.324 143.857 95.869 2.476 87.285 156.008 -147.632 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.5 ' CB ' ' HB3' ' A' ' 11' ' ' ASN . 0.0 OUTLIER -94.24 57.71 2.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.275 -0.891 . . . . 6.1900000000000004 110.094 179.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.56 -4.6 67.97 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.503 -1.439 . . . . 4.0499999999999998 109.503 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.49 32.68 4.44 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.516 -1.434 . . . . 4.2699999999999996 109.516 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 11' ' ' ASN . 32.1 tt0 -161.15 41.5 0.15 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.222 -1.163 . . . . 4.6200000000000001 110.339 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.5 ' HB3' ' CB ' ' A' ' 7' ' ' ARG . 0.1 OUTLIER 171.14 -153.26 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.232 -0.917 . . . . 3.4300000000000002 110.368 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.566 ' CE1' ' HB3' ' A' ' 29' ' ' ALA . 0.8 OUTLIER 44.48 -170.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.361 -0.837 . . . . 2.5699999999999998 110.05 -179.7 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.618 ' CD2' ' N ' ' A' ' 13' ' ' LEU . 1.3 mm? -111.84 130.04 55.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.122 -0.986 . . . . 2.5 110.162 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.602 ' HD2' ' CH2' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -128.26 130.57 48.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.32 -0.863 . . . . 2.1299999999999999 110.144 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.672 ' O ' ' HA ' ' A' ' 25' ' ' VAL . 25.4 mm -128.62 136.99 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.214 -0.929 . . . . 1.8500000000000001 110.573 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.708 ' CB ' ' HB3' ' A' ' 43' ' ' LYS . 3.6 m-90 -93.68 109.53 21.18 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.596 -0.842 . . . . 0.5 109.569 178.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.594 ' HB2' ' HB3' ' A' ' 40' ' ' TRP . 3.3 p -110.17 125.72 53.34 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 120.188 -0.605 . . . . 1.45 110.164 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.49 ' O ' ' HB3' ' A' ' 19' ' ' SER . 1.7 t60 -116.88 127.84 54.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.102 -0.999 . . . . 2.3300000000000001 110.118 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.586 ' OG ' ' CE2' ' A' ' 40' ' ' TRP . 1.1 p 177.26 166.85 0.59 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.184 -0.947 . . . . 1.0900000000000001 110.47 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 21' ' ' GLY . . . 42.04 -117.97 1.45 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.957 -1.257 . . . . 1.8600000000000001 109.957 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 20' ' ' GLY . . . -41.6 -94.95 0.01 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.903 -1.279 . . . . 1.5 109.903 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -147.55 -168.37 3.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -1.16 . . . . 2.96 110.399 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 18' ' ' HIS . 8.8 pt20 -69.69 153.89 42.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.355 -0.84 . . . . 2.5699999999999998 110.439 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.8 t -171.65 129.97 0.68 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.322 -0.861 . . . . 1.02 109.702 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.672 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 2.5 p -90.38 122.79 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.049 -1.032 . . . . 1.8600000000000001 110.788 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 15' ' ' ILE . 0.4 OUTLIER -89.07 143.81 26.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.382 -0.824 . . . . 1.8300000000000001 109.317 179.116 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 1.123 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 1.3 t -128.75 118.42 22.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.074 -1.016 . . . . 1.3 111.065 -179.309 -147.632 156.008 143.857 87.285 2.476 95.869 -33.324 -43.707 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.631 ' CD1' ' N ' ' A' ' 28' ' ' TYR . 1.4 p90 -122.09 -164.08 1.13 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.358 -0.839 . . . . 2.1800000000000002 109.422 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.607 ' HA ' ' CD2' ' A' ' 13' ' ' LEU . . . -143.97 163.1 34.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.978 -1.076 . . . . 1.9299999999999999 112.179 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.485 ' OD1' ' N ' ' A' ' 30' ' ' ASN . 2.3 m-20 65.04 -162.65 0.27 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.113 0.959 . . . . 1.97 112.044 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.803 ' HA ' ' CG2' ' A' ' 83' ' ' ILE . 30.0 ptt180 -117.43 158.44 24.47 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.458 0.647 . . . . 3.98 110.191 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.533 ' O ' ' HA ' ' A' ' 82' ' ' GLU . . . 143.09 171.82 13.73 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.296 -1.522 . . . . 0.68000000000000005 109.296 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.721 ' HA ' ' HA ' ' A' ' 82' ' ' GLU . 26.7 ptt180 -103.42 136.26 43.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.272 -1.134 . . . . 3.79 110.775 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.57 ' CG2' ' HB ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -135.34 114.32 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.514 -0.741 . . . . 1.3899999999999999 110.225 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.473 ' HA ' ' HB3' ' A' ' 80' ' ' SER . 8.1 t70 -42.94 136.82 2.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 2.27 110.081 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.521 ' CE2' HD12 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -99.96 -40.01 7.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.17 -0.956 . . . . 2.2000000000000002 110.209 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.72 -6.12 3.19 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.852 -1.299 . . . . 0.57999999999999996 109.852 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.535 ' O ' ' CG ' ' A' ' 77' ' ' LYS . . . 81.42 16.67 73.19 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.52 -1.432 . . . . 0.38 109.52 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.622 ' CD1' ' HG3' ' A' ' 77' ' ' LYS . 0.0 OUTLIER 173.57 81.85 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.368 -1.078 . . . . 0.58999999999999997 109.788 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.594 ' HB3' ' HB2' ' A' ' 17' ' ' SER . 15.6 m95 -161.43 69.99 0.34 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.141 -0.974 . . . . 0.56999999999999995 110.934 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.639 ' CG2' ' CG2' ' A' ' 78' ' ' VAL . 0.5 OUTLIER -137.07 162.81 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.023 -1.048 . . . . 1.1299999999999999 111.344 179.508 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.617 ' N ' ' O ' ' A' ' 16' ' ' TRP . 36.1 t0 176.66 -0.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.611 -0.885 . . . . 1.28 108.611 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.708 ' HB3' ' CB ' ' A' ' 16' ' ' TRP . 8.8 ttmt 156.32 161.99 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.563 -0.902 . . . . 2.02 108.563 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.596 ' N ' ' HG2' ' A' ' 43' ' ' LYS . 3.5 mp -148.71 135.41 12.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 120.931 -1.106 . . . . 1.6399999999999999 110.612 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 14' ' ' LYS . 31.1 t -119.1 76.69 1.13 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.427 -0.796 . . . . 0.75 109.893 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.648 ' O ' ' N ' ' A' ' 66' ' ' TRP . 60.3 p -83.69 64.06 7.78 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.51 -0.744 . . . . 1.1399999999999999 109.158 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.653 ' HA2' ' HA ' ' A' ' 66' ' ' TRP . . . -91.39 55.95 3.15 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.889 -1.148 . . . . 0.93000000000000005 110.677 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.786 ' HA ' ' CZ3' ' A' ' 66' ' ' TRP . 2.6 t30 166.02 4.8 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.31 -1.112 . . . . 2.1200000000000001 111.242 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.6 ' HB2' ' CD1' ' A' ' 13' ' ' LEU . 3.1 m-80 -161.61 145.89 12.95 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.714 -1.241 . . . . 2.1699999999999999 111.304 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.657 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.0 OUTLIER -77.75 88.5 4.0 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 106.645 -1.613 . . . . 1.9099999999999999 106.645 177.817 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.731 ' HG ' ' CD1' ' A' ' 53' ' ' TYR . 4.3 tp -83.46 137.98 33.66 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.856 0.836 . . . . 1.2 113.092 -176.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.776 HG12 ' CB ' ' A' ' 62' ' ' ARG . 5.0 mt -122.06 119.0 57.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.522 -0.918 . . . . 1.1299999999999999 108.522 176.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.745 ' N ' ' CD1' ' A' ' 53' ' ' TYR . 0.1 OUTLIER -121.27 112.39 18.56 Favored 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 118.636 -1.226 . . . . 2.6800000000000002 110.196 179.026 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.592 ' CE2' ' HB2' ' A' ' 60' ' ' SER . 96.1 m-85 -62.63 98.56 0.12 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.552 -0.718 . . . . 2.1899999999999999 109.471 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.638 ' O ' ' N ' ' A' ' 58' ' ' GLY . 3.9 t0 -68.94 176.16 3.28 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.174 -0.953 . . . . 1.8 110.676 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.62 ' CB ' ' HB3' ' A' ' 77' ' ' LYS . . . -35.84 -30.63 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.361 -0.837 . . . . 1.1499999999999999 110.927 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.536 ' ND2' ' CB ' ' A' ' 75' ' ' PRO . 2.1 m-80 -89.92 21.79 3.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.313 -0.867 . . . . 1.8100000000000001 109.612 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.638 ' N ' ' O ' ' A' ' 55' ' ' ASP . . . 49.47 29.4 11.21 Favored Glycine 0 N--CA 1.482 1.721 0 N-CA-C 104.522 -3.431 . . . . 0.42999999999999999 104.522 -176.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.709 ' O ' ' N ' ' A' ' 61' ' ' VAL . 0.5 OUTLIER -77.51 84.33 3.9 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.844 -0.678 . . . . 1.3999999999999999 109.445 -178.396 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.592 ' HB2' ' CE2' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -48.02 83.26 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.627 -0.829 . . . . 0.59999999999999998 109.311 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.717 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 49.0 t -74.34 90.93 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 121.77 0.795 . . . . 1.1100000000000001 109.177 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.776 ' CB ' HG12 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -88.8 94.57 9.96 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 120.037 -0.665 . . . . 3.5499999999999998 111.753 -178.338 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.657 ' O ' ' HA ' ' A' ' 50' ' ' ASP . 27.9 t -80.96 149.37 5.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 106.692 -1.595 . . . . 1.3200000000000001 106.692 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.708 ' C ' ' HG3' ' A' ' 65' ' ' ARG . 3.9 p-10 -101.34 76.01 1.67 Allowed 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 118.649 -1.22 . . . . 1.28 109.784 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.807 ' HB2' ' CE3' ' A' ' 66' ' ' TRP . 0.0 OUTLIER 42.05 177.75 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.56 0.695 . . . . 2.73 111.512 179.497 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.807 ' CE3' ' HB2' ' A' ' 65' ' ' ARG . 21.9 m-90 31.81 58.42 0.33 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.609 -0.682 . . . . 2.0499999999999998 110.765 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.592 ' CB ' ' CG1' ' A' ' 63' ' ' VAL . 0.3 OUTLIER -155.2 132.89 11.3 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.45 -0.781 . . . . 2.2200000000000002 110.286 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.577 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 4.8 p-10 -112.88 106.84 15.23 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.258 -0.901 . . . . 1.6299999999999999 110.261 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.516 HG23 ' OH ' ' A' ' 53' ' ' TYR . 0.3 OUTLIER -120.07 158.56 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.169 -0.957 . . . . 2.1000000000000001 109.882 -179.927 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.59 HG21 ' O ' ' A' ' 42' ' ' ASP . 2.7 m -139.71 -167.02 2.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.014 -1.054 . . . . 1.0900000000000001 110.938 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.628 ' HB2' ' CG1' ' A' ' 41' ' ' VAL . 56.7 m-85 -146.49 46.72 0.54 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.459 -0.775 . . . . 2.3999999999999999 110.738 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 71' ' ' TYR . 47.4 Cg_endo -73.01 -0.63 9.33 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 O-C-N 123.906 1.477 . . . . 0.55000000000000004 110.178 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -144.39 -50.79 0.29 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 2.79 109.907 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.583 ' CB ' ' HD2' ' A' ' 75' ' ' PRO . 4.9 mtt180 -53.83 -176.28 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.457 -0.777 . . . . 3.3700000000000001 109.909 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.583 ' HD2' ' CB ' ' A' ' 74' ' ' ARG . 40.8 Cg_endo -68.36 107.11 1.52 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.776 1.408 . . . . 0.79000000000000004 110.223 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.576 ' O ' ' HB2' ' A' ' 77' ' ' LYS . 50.3 Cg_endo -88.04 101.0 0.44 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.044 1.549 . . . . 1.3999999999999999 111.529 -179.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.622 ' HG3' ' CD1' ' A' ' 39' ' ' TRP . 11.5 tttt 175.93 60.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.512 -0.742 . . . . 1.71 109.361 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.639 ' CG2' ' CG2' ' A' ' 41' ' ' VAL . 21.5 t -58.59 123.22 10.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.586 -0.696 . . . . 1.1100000000000001 110.402 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.53 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 4.2 m120 -84.78 -15.31 45.39 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.398 -0.814 . . . . 1.1000000000000001 109.916 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.494 ' HB3' ' O ' ' A' ' 79' ' ' ASN . 4.5 p 173.03 170.46 0.13 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.144 -0.973 . . . . 1.47 110.806 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.682 ' CG2' ' N ' ' A' ' 82' ' ' GLU . 2.0 mt -111.12 176.34 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-O 121.873 0.844 . . . . 1.4399999999999999 109.312 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.747 ' O ' ' CD1' ' A' ' 84' ' ' LEU . 7.3 tt0 -175.76 75.87 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.184 0 C-N-CA 119.796 -0.761 . . . . 1.5 110.02 178.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.803 ' CG2' ' HA ' ' A' ' 31' ' ' ARG . 4.3 mt -75.16 147.67 8.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 108.519 -0.919 . . . . 1.21 108.519 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.747 ' CD1' ' O ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.79 0 C-N-CA 118.436 -1.306 . . . . 1.3 110.554 178.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.806 HD12 ' CD2' ' A' ' 28' ' ' TYR . 22.5 mm . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.614 0.721 . . . . 1.69 110.3 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 1.055 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -158.5 166.61 31.76 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.598 -0.689 . . . . 2.14 110.018 179.67 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.716 ' O ' HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -99.97 120.42 39.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.189 -0.944 . . . . 3.37 110.261 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.898 HG21 ' HB2' ' A' ' 29' ' ' ALA . 4.6 m -159.92 130.38 3.6 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.227 -0.92 . . . . 0.8 110.161 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 6' ' ' CYS . 47.1 Cg_endo -73.67 57.05 3.59 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.978 1.515 . . . . 1.18 110.668 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.999 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 7.7 m 57.51 160.5 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.156 -0.965 . . . . 1.31 110.279 179.785 -43.707 -33.324 143.857 95.869 2.476 87.285 156.008 -147.632 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.527 ' CB ' ' HB3' ' A' ' 11' ' ' ASN . 0.0 OUTLIER -94.24 57.71 2.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.275 -0.891 . . . . 5.48 110.094 179.956 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.56 -4.6 67.97 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.503 -1.439 . . . . 4.05 109.503 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.49 32.68 4.44 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.516 -1.434 . . . . 3.7 109.516 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.48 ' O ' ' CB ' ' A' ' 11' ' ' ASN . 32.1 tt0 -161.15 41.5 0.15 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.222 -1.163 . . . . 4.62 110.339 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.527 ' HB3' ' CB ' ' A' ' 7' ' ' ARG . 1.4 t-20 171.14 -153.26 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.232 -0.917 . . . . 3.24 110.368 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.508 ' O ' HD13 ' A' ' 13' ' ' LEU . 0.8 OUTLIER 44.48 -170.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.361 -0.837 . . . . 1.68 110.05 -179.7 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.891 HD23 ' HA ' ' A' ' 29' ' ' ALA . 1.3 mm? -111.84 130.04 55.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.122 -0.986 . . . . 1.9 110.162 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.981 ' HD2' HG21 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -128.26 130.57 48.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.32 -0.863 . . . . 1.39 110.144 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 1.137 ' CD1' HG23 ' A' ' 44' ' ' ILE . 25.4 mm -128.62 136.99 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.214 -0.929 . . . . 1.2 110.573 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.714 ' CB ' ' HB3' ' A' ' 43' ' ' LYS . 3.6 m-90 -93.68 109.53 21.18 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.596 -0.842 . . . . 0.44 109.569 178.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.621 ' HA ' ' CA ' ' A' ' 41' ' ' VAL . 3.3 p -110.17 125.72 53.34 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 120.188 -0.605 . . . . 1.21 110.164 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.514 ' HB2' ' HB2' ' A' ' 42' ' ' ASP . 1.7 t60 -116.88 127.84 54.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.102 -0.999 . . . . 1.64 110.118 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.577 ' OG ' ' CE2' ' A' ' 40' ' ' TRP . 1.1 p 177.26 166.85 0.59 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.184 -0.947 . . . . 1.09 110.47 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 21' ' ' GLY . . . 42.04 -117.97 1.45 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.957 -1.257 . . . . 1.86 109.957 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 20' ' ' GLY . . . -41.6 -94.95 0.01 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.903 -1.279 . . . . 0.85 109.903 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -147.55 -168.37 3.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -1.16 . . . . 2.27 110.399 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.452 ' HA ' ' HA ' ' A' ' 18' ' ' HIS . 8.8 pt20 -69.69 153.89 42.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.355 -0.84 . . . . 2.34 110.439 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.8 t -171.65 129.97 0.68 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.322 -0.861 . . . . 0.66 109.702 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.981 HG21 ' HD2' ' A' ' 14' ' ' LYS . 2.5 p -90.38 122.79 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.049 -1.032 . . . . 1.32 110.788 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 15' ' ' ILE . 0.4 OUTLIER -89.07 143.81 26.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.382 -0.824 . . . . 1.83 109.317 179.116 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.999 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 1.3 t -128.75 118.42 22.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.074 -1.016 . . . . 1.21 111.065 -179.309 -147.632 156.008 143.857 87.285 2.476 95.869 -33.324 -43.707 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.806 ' CD2' HD12 ' A' ' 1' ' ' ILE . 1.4 p90 -122.09 -164.08 1.13 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.358 -0.839 . . . . 1.29 109.422 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 1.055 ' HB3' ' HB3' ' A' ' 2' ' ' ASP . . . -143.97 163.1 34.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.978 -1.076 . . . . 1.39 112.179 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.485 ' OD1' ' N ' ' A' ' 30' ' ' ASN . 2.3 m-20 65.04 -162.65 0.27 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.113 0.959 . . . . 1.97 112.044 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.785 ' HA ' ' CG2' ' A' ' 83' ' ' ILE . 30.0 ptt180 -117.43 158.44 24.47 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.458 0.647 . . . . 3.5 110.191 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 82' ' ' GLU . . . 143.09 171.82 13.73 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.296 -1.522 . . . . 0.55 109.296 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.619 ' HA ' ' HA ' ' A' ' 82' ' ' GLU . 26.7 ptt180 -103.42 136.26 43.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.272 -1.134 . . . . 3.32 110.775 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.598 HG23 ' HB ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -135.34 114.32 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.514 -0.741 . . . . 0.75 110.225 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.503 ' HA ' ' HB3' ' A' ' 80' ' ' SER . 8.1 t70 -42.94 136.82 2.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 2.27 110.081 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.496 ' CE2' HD11 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -99.96 -40.01 7.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.17 -0.956 . . . . 1.29 110.209 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.72 -6.12 3.19 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.852 -1.299 . . . . 0.58 109.852 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.535 ' O ' ' CG ' ' A' ' 77' ' ' LYS . . . 81.42 16.67 73.19 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.52 -1.432 . . . . 0.31 109.52 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.621 ' CD1' ' HG3' ' A' ' 77' ' ' LYS . 0.0 OUTLIER 173.57 81.85 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.368 -1.078 . . . . 0.52 109.788 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.615 ' HB3' ' HB2' ' A' ' 17' ' ' SER . 15.6 m95 -161.43 69.99 0.34 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.141 -0.974 . . . . 0.48 110.934 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.852 HG23 HG21 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -137.07 162.81 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.023 -1.048 . . . . 0.48 111.344 179.508 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.679 ' C ' HG23 ' A' ' 70' ' ' THR . 36.1 t0 176.66 -0.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.611 -0.885 . . . . 1.28 108.611 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.989 ' CA ' HG23 ' A' ' 70' ' ' THR . 8.8 ttmt 156.32 161.99 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.563 -0.902 . . . . 1.43 108.563 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.137 HG23 ' CD1' ' A' ' 15' ' ' ILE . 3.5 mp -148.71 135.41 12.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 120.931 -1.106 . . . . 1.01 110.612 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.493 ' HB3' ' HB3' ' A' ' 14' ' ' LYS . 31.1 t -119.1 76.69 1.13 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.427 -0.796 . . . . 0.34 109.893 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.81 ' CG2' HD23 ' A' ' 51' ' ' LEU . 60.3 p -83.69 64.06 7.78 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.51 -0.744 . . . . 0.46 109.158 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.658 ' HA2' ' HA ' ' A' ' 66' ' ' TRP . . . -91.39 55.95 3.15 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.889 -1.148 . . . . 0.93 110.677 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.826 ' HA ' ' CZ3' ' A' ' 66' ' ' TRP . 2.6 t30 166.02 4.8 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.31 -1.112 . . . . 1.68 111.242 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.665 ' HB2' HD11 ' A' ' 13' ' ' LEU . 3.1 m-80 -161.61 145.89 12.95 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.714 -1.241 . . . . 2.17 111.304 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.715 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.0 OUTLIER -77.75 88.5 4.0 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 106.645 -1.613 . . . . 1.91 106.645 177.817 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.81 HD23 ' CG2' ' A' ' 46' ' ' THR . 4.3 tp -83.46 137.98 33.66 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.856 0.836 . . . . 0.51 113.092 -176.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.038 HG13 HD11 ' A' ' 84' ' ' LEU . 5.0 mt -122.06 119.0 57.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.522 -0.918 . . . . 0.3 108.522 176.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.745 ' CD1' ' N ' ' A' ' 53' ' ' TYR . 0.1 OUTLIER -121.27 112.39 18.56 Favored 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 118.636 -1.226 . . . . 1.72 110.196 179.026 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.612 ' CE2' ' HB2' ' A' ' 60' ' ' SER . 96.1 m-85 -62.63 98.56 0.12 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.552 -0.718 . . . . 1.26 109.471 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.638 ' O ' ' N ' ' A' ' 58' ' ' GLY . 3.9 t0 -68.94 176.16 3.28 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.174 -0.953 . . . . 1.8 110.676 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 1.036 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . . . -35.84 -30.63 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.361 -0.837 . . . . 0.47 110.927 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.526 ' N ' ' O ' ' A' ' 55' ' ' ASP . 3.9 m120 -89.92 21.79 3.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.313 -0.867 . . . . 1.29 109.612 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.638 ' N ' ' O ' ' A' ' 55' ' ' ASP . . . 49.47 29.4 11.21 Favored Glycine 0 N--CA 1.482 1.721 0 N-CA-C 104.522 -3.431 . . . . 0.39 104.522 -176.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.709 ' O ' ' N ' ' A' ' 61' ' ' VAL . 0.5 OUTLIER -77.51 84.33 3.9 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.844 -0.678 . . . . 1.4 109.445 -178.396 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.612 ' HB2' ' CE2' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -48.02 83.26 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.627 -0.829 . . . . 0.28 109.311 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.963 HG21 ' OH ' ' A' ' 71' ' ' TYR . 49.0 t -74.34 90.93 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 121.77 0.795 . . . . 0.34 109.177 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.782 ' CB ' HG12 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -88.8 94.57 9.96 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 120.037 -0.665 . . . . 3.07 111.753 -178.338 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.715 ' O ' ' HA ' ' A' ' 50' ' ' ASP . 27.9 t -80.96 149.37 5.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 106.692 -1.595 . . . . 0.68 106.692 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.705 ' C ' ' HG3' ' A' ' 65' ' ' ARG . 3.9 p-10 -101.34 76.01 1.67 Allowed 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 118.649 -1.22 . . . . 1.28 109.784 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.82 ' HB2' ' CE3' ' A' ' 66' ' ' TRP . 0.0 OUTLIER 42.05 177.75 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.56 0.695 . . . . 2.31 111.512 179.497 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.826 ' CZ3' ' HA ' ' A' ' 48' ' ' ASN . 21.9 m-90 31.81 58.42 0.33 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.609 -0.682 . . . . 1.6 110.765 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.592 ' CB ' ' CG1' ' A' ' 63' ' ' VAL . 0.3 OUTLIER -155.2 132.89 11.3 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.45 -0.781 . . . . 1.29 110.286 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.618 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 4.8 p-10 -112.88 106.84 15.23 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.258 -0.901 . . . . 1.63 110.261 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.641 HG21 ' OH ' ' A' ' 53' ' ' TYR . 0.3 OUTLIER -120.07 158.56 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.169 -0.957 . . . . 1.4 109.882 -179.927 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.989 HG23 ' CA ' ' A' ' 43' ' ' LYS . 2.7 m -139.71 -167.02 2.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.014 -1.054 . . . . 0.41 110.938 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.963 ' OH ' HG21 ' A' ' 61' ' ' VAL . 56.7 m-85 -146.49 46.72 0.54 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.459 -0.775 . . . . 1.49 110.738 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 71' ' ' TYR . 47.4 Cg_endo -73.01 -0.63 9.33 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 O-C-N 123.906 1.477 . . . . 0.55 110.178 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -144.39 -50.79 0.29 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 2.21 109.907 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.593 ' CB ' ' HD2' ' A' ' 75' ' ' PRO . 4.9 mtt180 -53.83 -176.28 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.457 -0.777 . . . . 2.77 109.909 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 1.036 ' HB2' ' HB3' ' A' ' 56' ' ' ALA . 40.8 Cg_endo -68.36 107.11 1.52 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.776 1.408 . . . . 0.71 110.223 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.576 ' O ' ' HB2' ' A' ' 77' ' ' LYS . 50.3 Cg_endo -88.04 101.0 0.44 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.044 1.549 . . . . 1.4 111.529 -179.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.651 ' HB3' ' CB ' ' A' ' 56' ' ' ALA . 11.5 tttt 175.93 60.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.512 -0.742 . . . . 1.24 109.361 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.852 HG21 HG23 ' A' ' 41' ' ' VAL . 21.5 t -58.59 123.22 10.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.586 -0.696 . . . . 0.23 110.402 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.502 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 29.6 m-20 -84.78 -15.31 45.39 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.398 -0.814 . . . . 1.1 109.916 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.503 ' HB3' ' HA ' ' A' ' 35' ' ' ASP . 4.5 p 173.03 170.46 0.13 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.144 -0.973 . . . . 1.22 110.806 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.682 ' CG2' ' N ' ' A' ' 82' ' ' GLU . 2.0 mt -111.12 176.34 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-O 121.873 0.844 . . . . 0.73 109.312 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.747 ' O ' ' CD1' ' A' ' 84' ' ' LEU . 7.3 tt0 -175.76 75.87 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.184 0 C-N-CA 119.796 -0.761 . . . . 1.5 110.02 178.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.866 ' C ' HD13 ' A' ' 84' ' ' LEU . 4.3 mt -75.16 147.67 8.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 108.519 -0.919 . . . . 0.47 108.519 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.038 HD11 HG13 ' A' ' 52' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.79 0 C-N-CA 118.436 -1.306 . . . . 1.3 110.554 178.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.806 HD12 ' CD2' ' A' ' 28' ' ' TYR . 22.5 mm . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.614 0.721 . . . . 1.6899999999999999 110.3 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 1.055 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -158.5 166.61 31.76 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.598 -0.689 . . . . 2.1400000000000001 110.018 179.67 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.716 ' O ' HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -99.97 120.42 39.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.189 -0.944 . . . . 3.3700000000000001 110.261 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.898 HG21 ' HB2' ' A' ' 29' ' ' ALA . 4.6 m -159.92 130.38 3.6 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.227 -0.92 . . . . 0.80000000000000004 110.161 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 6' ' ' CYS . 47.1 Cg_endo -73.67 57.05 3.59 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.978 1.515 . . . . 1.1799999999999999 110.668 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.999 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 7.7 m 57.51 160.5 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.156 -0.965 . . . . 1.3100000000000001 110.279 179.785 -43.707 -33.324 143.857 95.869 2.476 87.285 156.008 -147.632 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.527 ' CB ' ' HB3' ' A' ' 11' ' ' ASN . 0.0 OUTLIER -94.24 57.71 2.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.275 -0.891 . . . . 5.4800000000000004 110.094 179.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.56 -4.6 67.97 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.503 -1.439 . . . . 4.0499999999999998 109.503 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.49 32.68 4.44 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.516 -1.434 . . . . 3.7000000000000002 109.516 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.48 ' O ' ' CB ' ' A' ' 11' ' ' ASN . 32.1 tt0 -161.15 41.5 0.15 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.222 -1.163 . . . . 4.6200000000000001 110.339 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.527 ' HB3' ' CB ' ' A' ' 7' ' ' ARG . 0.1 OUTLIER 171.14 -153.26 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.232 -0.917 . . . . 3.2400000000000002 110.368 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.508 ' O ' HD13 ' A' ' 13' ' ' LEU . 0.8 OUTLIER 44.48 -170.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.361 -0.837 . . . . 1.6799999999999999 110.05 -179.7 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.891 HD23 ' HA ' ' A' ' 29' ' ' ALA . 1.3 mm? -111.84 130.04 55.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.122 -0.986 . . . . 1.8999999999999999 110.162 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.981 ' HD2' HG21 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -128.26 130.57 48.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.32 -0.863 . . . . 1.3899999999999999 110.144 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 1.137 ' CD1' HG23 ' A' ' 44' ' ' ILE . 25.4 mm -128.62 136.99 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.214 -0.929 . . . . 1.2 110.573 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.714 ' CB ' ' HB3' ' A' ' 43' ' ' LYS . 3.6 m-90 -93.68 109.53 21.18 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.596 -0.842 . . . . 0.44 109.569 178.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.621 ' HA ' ' CA ' ' A' ' 41' ' ' VAL . 3.3 p -110.17 125.72 53.34 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 120.188 -0.605 . . . . 1.21 110.164 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.514 ' HB2' ' HB2' ' A' ' 42' ' ' ASP . 1.7 t60 -116.88 127.84 54.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.102 -0.999 . . . . 1.6399999999999999 110.118 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.577 ' OG ' ' CE2' ' A' ' 40' ' ' TRP . 1.1 p 177.26 166.85 0.59 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.184 -0.947 . . . . 1.0900000000000001 110.47 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 21' ' ' GLY . . . 42.04 -117.97 1.45 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.957 -1.257 . . . . 1.8600000000000001 109.957 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 20' ' ' GLY . . . -41.6 -94.95 0.01 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.903 -1.279 . . . . 0.84999999999999998 109.903 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -147.55 -168.37 3.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -1.16 . . . . 2.27 110.399 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.452 ' HA ' ' HA ' ' A' ' 18' ' ' HIS . 8.8 pt20 -69.69 153.89 42.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.355 -0.84 . . . . 2.3399999999999999 110.439 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.8 t -171.65 129.97 0.68 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.322 -0.861 . . . . 0.66000000000000003 109.702 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.981 HG21 ' HD2' ' A' ' 14' ' ' LYS . 2.5 p -90.38 122.79 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.049 -1.032 . . . . 1.3200000000000001 110.788 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 15' ' ' ILE . 0.4 OUTLIER -89.07 143.81 26.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.382 -0.824 . . . . 1.8300000000000001 109.317 179.116 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.999 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 1.3 t -128.75 118.42 22.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.074 -1.016 . . . . 1.21 111.065 -179.309 -147.632 156.008 143.857 87.285 2.476 95.869 -33.324 -43.707 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.806 ' CD2' HD12 ' A' ' 1' ' ' ILE . 1.4 p90 -122.09 -164.08 1.13 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.358 -0.839 . . . . 1.29 109.422 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 1.055 ' HB3' ' HB3' ' A' ' 2' ' ' ASP . . . -143.97 163.1 34.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.978 -1.076 . . . . 1.3899999999999999 112.179 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.485 ' OD1' ' N ' ' A' ' 30' ' ' ASN . 2.3 m-20 65.04 -162.65 0.27 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.113 0.959 . . . . 1.97 112.044 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.785 ' HA ' ' CG2' ' A' ' 83' ' ' ILE . 30.0 ptt180 -117.43 158.44 24.47 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.458 0.647 . . . . 3.5 110.191 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 82' ' ' GLU . . . 143.09 171.82 13.73 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.296 -1.522 . . . . 0.55000000000000004 109.296 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.619 ' HA ' ' HA ' ' A' ' 82' ' ' GLU . 26.7 ptt180 -103.42 136.26 43.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.272 -1.134 . . . . 3.3199999999999998 110.775 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.598 HG23 ' HB ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -135.34 114.32 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.514 -0.741 . . . . 0.75 110.225 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.503 ' HA ' ' HB3' ' A' ' 80' ' ' SER . 8.1 t70 -42.94 136.82 2.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 2.27 110.081 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.496 ' CE2' HD11 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -99.96 -40.01 7.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.17 -0.956 . . . . 1.29 110.209 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.72 -6.12 3.19 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.852 -1.299 . . . . 0.57999999999999996 109.852 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.535 ' O ' ' CG ' ' A' ' 77' ' ' LYS . . . 81.42 16.67 73.19 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.52 -1.432 . . . . 0.31 109.52 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.621 ' CD1' ' HG3' ' A' ' 77' ' ' LYS . 0.0 OUTLIER 173.57 81.85 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.368 -1.078 . . . . 0.52000000000000002 109.788 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.615 ' HB3' ' HB2' ' A' ' 17' ' ' SER . 15.6 m95 -161.43 69.99 0.34 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.141 -0.974 . . . . 0.47999999999999998 110.934 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.852 HG23 HG21 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -137.07 162.81 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.023 -1.048 . . . . 0.47999999999999998 111.344 179.508 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.679 ' C ' HG23 ' A' ' 70' ' ' THR . 36.1 t0 176.66 -0.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.611 -0.885 . . . . 1.28 108.611 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.989 ' CA ' HG23 ' A' ' 70' ' ' THR . 8.8 ttmt 156.32 161.99 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.563 -0.902 . . . . 1.4299999999999999 108.563 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.137 HG23 ' CD1' ' A' ' 15' ' ' ILE . 3.5 mp -148.71 135.41 12.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 120.931 -1.106 . . . . 1.01 110.612 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.493 ' HB3' ' HB3' ' A' ' 14' ' ' LYS . 31.1 t -119.1 76.69 1.13 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.427 -0.796 . . . . 0.34000000000000002 109.893 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.81 ' CG2' HD23 ' A' ' 51' ' ' LEU . 60.3 p -83.69 64.06 7.78 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.51 -0.744 . . . . 0.46000000000000002 109.158 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.658 ' HA2' ' HA ' ' A' ' 66' ' ' TRP . . . -91.39 55.95 3.15 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.889 -1.148 . . . . 0.93000000000000005 110.677 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.826 ' HA ' ' CZ3' ' A' ' 66' ' ' TRP . 2.6 t30 166.02 4.8 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.31 -1.112 . . . . 1.6799999999999999 111.242 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.665 ' HB2' HD11 ' A' ' 13' ' ' LEU . 3.1 m-80 -161.61 145.89 12.95 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.714 -1.241 . . . . 2.1699999999999999 111.304 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.715 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.0 OUTLIER -77.75 88.5 4.0 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 106.645 -1.613 . . . . 1.9099999999999999 106.645 177.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.81 HD23 ' CG2' ' A' ' 46' ' ' THR . 4.3 tp -83.46 137.98 33.66 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.856 0.836 . . . . 0.51000000000000001 113.092 -176.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.038 HG13 HD11 ' A' ' 84' ' ' LEU . 5.0 mt -122.06 119.0 57.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.522 -0.918 . . . . 0.29999999999999999 108.522 176.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.745 ' N ' ' CD1' ' A' ' 53' ' ' TYR . 0.1 OUTLIER -121.27 112.39 18.56 Favored 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 118.636 -1.226 . . . . 1.72 110.196 179.026 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.612 ' CE2' ' HB2' ' A' ' 60' ' ' SER . 96.1 m-85 -62.63 98.56 0.12 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.552 -0.718 . . . . 1.26 109.471 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.638 ' O ' ' N ' ' A' ' 58' ' ' GLY . 3.9 t0 -68.94 176.16 3.28 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.174 -0.953 . . . . 1.8 110.676 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 1.036 ' HB3' ' HB2' ' A' ' 75' ' ' PRO . . . -35.84 -30.63 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.361 -0.837 . . . . 0.46999999999999997 110.927 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.536 ' ND2' ' CB ' ' A' ' 75' ' ' PRO . 2.1 m-80 -89.92 21.79 3.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.313 -0.867 . . . . 1.29 109.612 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.638 ' N ' ' O ' ' A' ' 55' ' ' ASP . . . 49.47 29.4 11.21 Favored Glycine 0 N--CA 1.482 1.721 0 N-CA-C 104.522 -3.431 . . . . 0.39000000000000001 104.522 -176.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.709 ' O ' ' N ' ' A' ' 61' ' ' VAL . 0.5 OUTLIER -77.51 84.33 3.9 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.844 -0.678 . . . . 1.3999999999999999 109.445 -178.396 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.612 ' HB2' ' CE2' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -48.02 83.26 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.627 -0.829 . . . . 0.28000000000000003 109.311 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.963 HG21 ' OH ' ' A' ' 71' ' ' TYR . 49.0 t -74.34 90.93 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 121.77 0.795 . . . . 0.34000000000000002 109.177 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.782 ' CB ' HG12 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -88.8 94.57 9.96 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 120.037 -0.665 . . . . 3.0699999999999998 111.753 -178.338 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.715 ' O ' ' HA ' ' A' ' 50' ' ' ASP . 27.9 t -80.96 149.37 5.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 106.692 -1.595 . . . . 0.68000000000000005 106.692 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.705 ' C ' ' HG3' ' A' ' 65' ' ' ARG . 3.9 p-10 -101.34 76.01 1.67 Allowed 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 118.649 -1.22 . . . . 1.28 109.784 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.82 ' HB2' ' CE3' ' A' ' 66' ' ' TRP . 0.0 OUTLIER 42.05 177.75 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.56 0.695 . . . . 2.3100000000000001 111.512 179.497 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.826 ' CZ3' ' HA ' ' A' ' 48' ' ' ASN . 21.9 m-90 31.81 58.42 0.33 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.609 -0.682 . . . . 1.6000000000000001 110.765 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.592 ' CB ' ' CG1' ' A' ' 63' ' ' VAL . 0.3 OUTLIER -155.2 132.89 11.3 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.45 -0.781 . . . . 1.29 110.286 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.618 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 4.8 p-10 -112.88 106.84 15.23 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.258 -0.901 . . . . 1.6299999999999999 110.261 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.641 HG21 ' OH ' ' A' ' 53' ' ' TYR . 0.3 OUTLIER -120.07 158.56 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.169 -0.957 . . . . 1.3999999999999999 109.882 -179.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.989 HG23 ' CA ' ' A' ' 43' ' ' LYS . 2.7 m -139.71 -167.02 2.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.014 -1.054 . . . . 0.40999999999999998 110.938 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.963 ' OH ' HG21 ' A' ' 61' ' ' VAL . 56.7 m-85 -146.49 46.72 0.54 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.459 -0.775 . . . . 1.49 110.738 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 71' ' ' TYR . 47.4 Cg_endo -73.01 -0.63 9.33 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 O-C-N 123.906 1.477 . . . . 0.55000000000000004 110.178 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -144.39 -50.79 0.29 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 2.21 109.907 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.593 ' CB ' ' HD2' ' A' ' 75' ' ' PRO . 4.9 mtt180 -53.83 -176.28 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.457 -0.777 . . . . 2.77 109.909 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 1.036 ' HB2' ' HB3' ' A' ' 56' ' ' ALA . 40.8 Cg_endo -68.36 107.11 1.52 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.776 1.408 . . . . 0.70999999999999996 110.223 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.576 ' O ' ' HB2' ' A' ' 77' ' ' LYS . 50.3 Cg_endo -88.04 101.0 0.44 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.044 1.549 . . . . 1.3999999999999999 111.529 -179.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.651 ' HB3' ' CB ' ' A' ' 56' ' ' ALA . 11.5 tttt 175.93 60.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.512 -0.742 . . . . 1.24 109.361 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.852 HG21 HG23 ' A' ' 41' ' ' VAL . 21.5 t -58.59 123.22 10.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.586 -0.696 . . . . 0.23000000000000001 110.402 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.502 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 4.2 m120 -84.78 -15.31 45.39 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.398 -0.814 . . . . 1.1000000000000001 109.916 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.503 ' HB3' ' HA ' ' A' ' 35' ' ' ASP . 4.5 p 173.03 170.46 0.13 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.144 -0.973 . . . . 1.22 110.806 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.682 ' CG2' ' N ' ' A' ' 82' ' ' GLU . 2.0 mt -111.12 176.34 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-O 121.873 0.844 . . . . 0.72999999999999998 109.312 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.747 ' O ' ' CD1' ' A' ' 84' ' ' LEU . 7.3 tt0 -175.76 75.87 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.184 0 C-N-CA 119.796 -0.761 . . . . 1.5 110.02 178.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.866 ' C ' HD13 ' A' ' 84' ' ' LEU . 4.3 mt -75.16 147.67 8.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 108.519 -0.919 . . . . 0.46999999999999997 108.519 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.038 HD11 HG13 ' A' ' 52' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.79 0 C-N-CA 118.436 -1.306 . . . . 1.3 110.554 178.499 . . . . . . . . 2 2 . 1 stop_ save_